HomeOpen Access NewsHealthcare Research

Healthcare Research

Exploring the barriers and enablers to healthy longevity

Didier Coeurnelle, Co-chair at Heales (Healthy Life Extension Society) and member of the board at the International Longevity Alliance, discusses developments in longevity research, promoters and barriers to healthy aging, and the importance of preventative approaches to care.

Scientists unveil terbium-161 breakthrough in targeted lymphoma treatment

A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.

Integrating clinical expertise enhances patient acceptance of AI in healthcare

A study by researchers from the University of Manchester and Cambridge explores the attitudes of AI in healthcare.

How deep brain stimulation alleviates symptoms of Parkinson’s disease

A new study has explored how deep brain stimulation positively impacts patients with Parkinson’s disease.

Adult-onset type 1 diabetes increases the risk of cardiovascular disease

A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.

NHS England abolition leaves patients and staff facing uncertain future, PAC warns

Public Accounts Committee (PAC) raises concerns over NHS England abolition and its impact on patients and staff.

Multiple chronic diseases linked to higher risk of depression

A new study shows that some combinations of chronic diseases could more than double the likelihood of a future depression diagnosis.

New research links poor oral health to chronic diseases

A major study has found that people with signs of gum disease are more likely to suffer from multiple chronic diseases.

Low-dose interleukin-2 found safe and effective for slowing motor neurone disease progression

A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).

FDA approves clinical trial for groundbreaking Hereditary Spastic Paraplegia treatment

BlackfinBio Limited has received approval from the FDA to trial a novel therapy for Hereditary Spastic Paraplegia.

AI breakthrough identifies active brain neurons

A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.

23.7% of people globally have mild cognitive impairment

A recent study has revealed the global prevalence of mild cognitive impairment and examined the key factors influencing its development.

First significant ischemic stroke therapy advancement since 2002

A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.

NICE new guidelines to reduce fragility in older people and lower hospital admission rates

Updated guidance recommends personalised assessments and previous medical history to reduce fragility in support of older and at-risk individuals.

Real-time kidney transplant monitoring model developed using warm perfusion

A collaborative team has created a new model that enables continuous monitoring of kidney transplants through warm machine perfusion of human organs.

New analysis shows NHS faced record winter pressures in 2024/25

The Health Foundation analysed publicly available data to assess NHS performance and the effects of winter pressures on the health service.

Researchers identify the key metabolic drivers of Parkinson’s disease

Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders